ICU Medical (ICUI) Announces Earnings Results, Beats Estimates By $0.34 EPS

ICU Medical (NASDAQ:ICUI) released its quarterly earnings results on Thursday. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.34, Briefing.com reports. ICU Medical had a net margin of 5.93% and a return on equity of 12.78%. The company had revenue of $327.20 million during the quarter, compared to the consensus estimate of $334.97 million. During the same period in the prior year, the firm earned $1.12 earnings per share. ICU Medical’s revenue was down 4.7% on a year-over-year basis. ICU Medical updated its FY 2018 guidance to $8.45-8.85 EPS and its FY18 guidance to $8.45-8.85 EPS.

Shares of NASDAQ ICUI traded down $28.23 on Friday, reaching $232.01. 689,193 shares of the company’s stock traded hands, compared to its average volume of 181,891. ICU Medical has a 12 month low of $196.33 and a 12 month high of $321.70. The company has a market capitalization of $5.31 billion, a price-to-earnings ratio of 35.99 and a beta of 0.65.

ICUI has been the subject of a number of research reports. ValuEngine downgraded shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $337.00 price target for the company in a research note on Wednesday, August 15th. TheStreet raised shares of ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. Finally, BidaskClub downgraded shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Thursday, September 20th.

In other ICU Medical news, VP Thomas D. Mccall sold 11,133 shares of the firm’s stock in a transaction that occurred on Friday, August 24th. The shares were sold at an average price of $302.56, for a total transaction of $3,368,400.48. Following the completion of the transaction, the vice president now owns 3,018 shares of the company’s stock, valued at $913,126.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Pfizer Inc sold 700,000 shares of the firm’s stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $284.35, for a total transaction of $199,045,000.00. The disclosure for this sale can be found here. Insiders have sold 711,920 shares of company stock valued at $202,651,956 in the last ninety days. Insiders own 12.50% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in ICUI. LPL Financial LLC bought a new position in shares of ICU Medical during the first quarter valued at approximately $218,000. State of Alaska Department of Revenue purchased a new stake in shares of ICU Medical during the second quarter valued at approximately $554,000. Xact Kapitalforvaltning AB grew its holdings in shares of ICU Medical by 18.4% during the second quarter. Xact Kapitalforvaltning AB now owns 2,572 shares of the medical instruments supplier’s stock valued at $755,000 after buying an additional 400 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of ICU Medical during the second quarter valued at approximately $230,000. Finally, Retirement Systems of Alabama grew its holdings in shares of ICU Medical by 1.1% during the second quarter. Retirement Systems of Alabama now owns 19,732 shares of the medical instruments supplier’s stock valued at $5,794,000 after buying an additional 206 shares during the last quarter. 73.51% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by WKRB News and is the property of of WKRB News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.wkrb13.com/2018/11/10/icu-medical-icui-announces-earnings-results-beats-estimates-by-0-34-eps.html.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: Stock Symbol

Earnings History for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply